[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
BioMed Central: question from a reader
- To: liblicense-l@lists.yale.edu
- Subject: BioMed Central: question from a reader
- From: Ann Okerson <okerson@pantheon.yale.edu>
- Date: Sun, 25 Aug 2002 19:12:58 EDT
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
QUESTION: Can anyone tell me who owns BioMed Central? I understand it is a subsidiary of Current Science Group, but who owns this company? I know it is commercial but don't know if it is a subsidiary of another company, is listed on the stock exchange or is privately owned. When I asked BioMed Central they referred me to a page with no details of ownership and then didn't reply to further questions. One of the contributing factors in the journal crisis is that scientists don't realise who they are giving a manuscript to, and often its not easy finding out. Are they obliged to make this information public? Thank you. Diane Lester *** ANSWER: First of all, one of the ways BioMed Central differs from other, conventional, publishers, is that authors are not 'giving' their article to us. They keep all the rights to their article, are not asked to transfer copyright, and are totally free to distribute their article in any way they like. What we provide, and what authors' institutions are paying for (a fraction, by the way, of what they collectively pay for articles published conventionally), is the service of organising and handling the process of having the article peer-reviewed, and, if accepted, published (given a unique bibliographic journal citation, DOI and URL) in open access, presented in various standardised formats (PDF and XML-generated HTML) and hotlinked (via CrossRef and others) and indexed (PubMed, Biosis and others) to enable optimum findability, citeability, dissemination, and 'embedding' in the network that science literature is. BioMed Central is part of the Current Science Group and wholly privately owned by the chairman Vitek Tracz (see http://www.biomedcentral.com/info/whoweare.asp). We are a commercial company, fully committed to open access (see our open access charter: http://www.biomedcentral.com/info/charter.asp) and protected from takeover by entities hostile to open access by a Board of Trustees consisting of eminent scientists also committed to open access (see http://www.biomedcentral.com/info/trustees.asp) With best regards, Jan Velterop, Publisher Tel +44 (0)20 7323 0323 www.biomedcentral.com
- Prev by Date: Re: Copyright of previous public domain
- Next by Date: Lippincott Williams & Wilkins Announcement
- Prev by thread: RE: Lippincott Williams & Wilkins Announcement
- Next by thread: Ingenta institute reports
- Index(es):